Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances-Reference-Cited by-同舟云学术

Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances

Published:1976 Issue:6 Volume:10 Page:425-432
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Wagner J. G.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00563079.pdf

Reference18 articles.

1. Albert, K.S., Hallmark, M.R., Sakmar, E., Weidler, D.J., Wagner, J.G.: Pharmacokinetics of diphenhydramine in man. J. Pharmacokin. Biopharm.3, 159?170 (1975)

2. Anton, A.H., Solomon, H.M.: Drug-protein binding. Ann. N. Y. Acad. Sci.226, 1?362 (1973)

3. Benya, T.J., Wagner, J.G.: Rapid equilibration of warfarin between rat tissue and plasma. J. Pharmacokin. Biopharm.3, 237?255 (1975)

4. Bischoff, K.B., Dedrick, R.L.: Thiopental pharmacokinetics. J. pharm. Sci.57, 1346?1351 (1968)

5. Coffey, J.J.: Effects of protein binding of drugs on areas under plasma concentration-time curves. J. pharm. Sci.61, 138?139 (1972)

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PK – TK Considerations of Distribution Mechanisms and Rate Equations;Handbook of Pharmacokinetics and Toxicokinetics;2023-07-03

2. Nonlinear Drug Binding to Plasma Proteins;The ADME Encyclopedia;2022

3. Factor Xa Levels in Patients Receiving Prophylactic Enoxaparin Sodium in the Intensive Care Unit of an Academic Hospital;Indian Journal of Critical Care Medicine;2021-08-12

4. New Equilibrium Models of Drug-Receptor Interactions Derived from Target-Mediated Drug Disposition;The AAPS Journal;2018-05-14

5. In vivo potency revisited – Keep the target in sight;Pharmacology & Therapeutics;2018-04